Bafna Pharmaceuticals Limited
NSE: BAFNAPH | Information Technology
Market Fundamentals
Stock Intelligence & News
Trident Texofab Ltd (540726)
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you about that, based on the recommendation of the Audit Committee, the Board of Directors at its Meeting held today i.e. October 03, 2026, has approved the appointment of M/s. A Bafna & Associates, Chartered Accountants, (ICAI Firm Registration No.: 121901W), as Statutory Auditors subject to approval of the Members.
Read Full Analysis →Pro Fin Capital Services Ltd (511557)
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dilkhush Bafna J
Read Full Analysis →Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Bafna Pharmaceuticals Ltd (532989)
Intimation for Closure of Trading Window
Read Full Analysis →Neptune Logitek Ltd (544663)
Intimation of Resignation of Mr. Mukesh Bafna as an Independent Director of the company.
Read Full Analysis →Who Was Madan Bafna? Veteran Maharashtra Politician Dies At 87 In Pune
Madan Bafna dies at 87 of a heart attack
Read Full Analysis →Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited has informed the Exchange regarding Proceedings of the 31st Annual General Meeting of the Company held on September 11, 2026 |SUBJECT: Shareholders meeting
Read Full Analysis →Bafna Pharmaceuticals Ltd (532989)
We herewith enclose the Outcome / Proceedings of the 31st Annual General Meeting of the Company held on September 11, 2026.
Read Full Analysis →Esprit Stones Limited
Esprit Stones Limited has informed the Exchange regarding Re-appointment of M/s. A Bafna & Co. as Statutory Auditor of the company. |SUBJECT: Appointment
Read Full Analysis →Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the 31st Annual General Meeting of the Company published in ''Business Standard'' and ''Makkal Kural'' on August 20, 2026 |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Get instant alerts when BAFNAPH breaks news
Join investors who track Bafna Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for BAFNAPH?
BAFNAPH is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Bafna Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding BAFNAPH to your custom watchlist.